Published in Cancer Weekly, February 7th, 2006
The protocol adopted by BKK requires use of the Digene HPV Test, also marketed as the DNAwithPap Test. It is the only U.S. Food & Drug Administration-approved test for high-risk types of the human papilloma virus, which cause virtually all cases of cervical cancer. The test is approved in the United States for use along with the Pap to screen women age 30 and older,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.